Search

Your search keyword '"Goodman, Marc T"' showing total 25 results
Start Over Author "Goodman, Marc T" Journal cancer causes & control
25 results on '"Goodman, Marc T"'

1. Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium

Author

Babic, Ana, Cramer, Daniel W, Kelemen, Linda E, Köbel, Martin, Steed, Helen, Webb, Penelope M, Johnatty, Sharon E, deFazio, Anna, Lambrechts, Diether, Goodman, Marc T, Heitz, Florian, Matsuo, Keitaro, Hosono, Satoyo, Karlan, Beth Y, Jensen, Allan, Kjær, Susanne K, Goode, Ellen L, Pejovic, Tanja, Moffitt, Melissa, Høgdall, Estrid, Høgdall, Claus, McNeish, Iain, and Terry, Kathryn L

Subjects
Health Services and Systems, Biomedical and Clinical Sciences, Health Sciences, Oncology and Carcinogenesis, Rare Diseases, Prevention, Clinical Research, Breast Cancer, Ovarian Cancer, Cancer, Aetiology, 2.1 Biological and endogenous factors, Adult, Aged, Biomarkers, Tumor, CA-125 Antigen, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Ovarian Neoplasms, Parity, Pregnancy, Prognosis, Ovarian cancer, CA125, Predictors, Biomarker, Public Health and Health Services, Epidemiology, Oncology and carcinogenesis
Abstract

PurposeCancer antigen 125 (CA125) is a glycoprotein expressed by epithelial cells of several normal tissue types and overexpressed by several epithelial cancers. Serum CA125 levels are mostly used as an aid in the diagnosis of ovarian cancer patients, to monitor response to treatment and detect cancer recurrence. Besides tumor characteristics, CA125 levels are also influenced by several epidemiologic factors, such as age, parity, and oral contraceptive use. Identifying factors that influence CA125 levels in ovarian cancer patients could aid in the interpretation of CA125 values for individuals.MethodsWe evaluated predictors of pretreatment CA125 in 13 studies participating in the Ovarian Cancer Association Consortium. This analysis included a total of 5,091 women with invasive epithelial ovarian cancer with pretreatment CA125 measurements. We used probit scores to account for variability in CA125 between studies and linear regression to estimate the association between epidemiologic factors and tumor characteristics and pretreatment CA125 levels.ResultsIn age-adjusted models, older age, history of pregnancy, history of tubal ligation, family history of breast cancer, and family history of ovarian cancer were associated with higher CA125 levels while endometriosis was associated with lower CA125 levels. After adjusting for tumor-related characteristics (stage, histology, grade), body mass index (BMI) higher than 30 kg/m2 was associated with 10% (95% CI 2, 19%) higher CA125 levels, while race (non-white vs. white) was associated with 15% (95% CI 4, 27%) higher CA125 levels.ConclusionOur results suggest that high BMI and race may influence CA125 levels independent of tumor characteristics. Validation is needed in studies that use a single assay for CA125 measurement and have a diverse study population.

Published
2017

2. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium

Author

Minlikeeva, Albina N, Freudenheim, Jo L, Cannioto, Rikki A, Szender, J Brian, Eng, Kevin H, Modugno, Francesmary, Ness, Roberta B, LaMonte, Michael J, Friel, Grace, Segal, Brahm H, Odunsi, Kunle, Mayor, Paul, Zsiros, Emese, Schmalfeldt, Barbara, Klapdor, Rüdiger, Dӧrk, Thilo, Hillemanns, Peter, Kelemen, Linda E, Kӧbel, Martin, Steed, Helen, de Fazio, Anna, on behalf of the Australian Ovarian Cancer Study Group, Jordan, Susan J, Nagle, Christina M, Risch, Harvey A, Rossing, Mary Anne, Doherty, Jennifer A, Goodman, Marc T, Edwards, Robert, Matsuo, Keitaro, Mizuno, Mika, Karlan, Beth Y, Kjær, Susanne K, Høgdall, Estrid, Jensen, Allan, Schildkraut, Joellen M, Terry, Kathryn L, Cramer, Daniel W, Bandera, Elisa V, Paddock, Lisa E, Kiemeney, Lambertus A, Massuger, Leon F, Kupryjanczyk, Jolanta, Berchuck, Andrew, Chang-Claude, Jenny, Diergaarde, Brenda, Webb, Penelope M, Moysich, Kirsten B, and on behalf of the Ovarian Cancer Association Consortium

Subjects
Epidemiology, Biomedical and Clinical Sciences, Health Sciences, Oncology and Carcinogenesis, Clinical Research, Cancer, Diabetes, Ovarian Cancer, Rare Diseases, Genetics, Cardiovascular, Detection, screening and diagnosis, 4.1 Discovery and preclinical testing of markers and technologies, Good Health and Well Being, Adrenergic beta-Antagonists, Adult, Aged, Diabetes Mellitus, Disease-Free Survival, Female, Heart Diseases, Humans, Hypertension, Hypoglycemic Agents, Insulin, Middle Aged, Ovarian Neoplasms, Risk, Survival Rate, Ovarian cancer prognosis, Medications, Mortality, Beta blockers, Australian Ovarian Cancer Study Group, Ovarian Cancer Association Consortium, Public Health and Health Services, Oncology and carcinogenesis
Abstract

PurposeSurvival following ovarian cancer diagnosis is generally low; understanding factors related to prognosis could be important to optimize treatment. The role of previously diagnosed comorbidities and use of medications for those conditions in relation to prognosis for ovarian cancer patients has not been studied extensively, particularly according to histological subtype.MethodsUsing pooled data from fifteen studies participating in the Ovarian Cancer Association Consortium, we examined the associations between history of hypertension, heart disease, diabetes, and medications taken for these conditions and overall survival (OS) and progression-free survival (PFS) among patients diagnosed with invasive epithelial ovarian carcinoma. We used Cox proportional hazards regression models adjusted for age and stage to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) overall and within strata of histological subtypes.ResultsHistory of diabetes was associated with increased risk of mortality (n = 7,674; HR = 1.12; 95% CI = 1.01-1.25). No significant mortality associations were observed for hypertension (n = 6,482; HR = 0.95; 95% CI = 0.88-1.02) or heart disease (n = 4,252; HR = 1.05; 95% CI = 0.87-1.27). No association of these comorbidities was found with PFS in the overall study population. However, among patients with endometrioid tumors, hypertension was associated with lower risk of progression (n = 339, HR = 0.54; 95% CI = 0.35-0.84). Comorbidity was not associated with OS or PFS for any of the other histological subtypes. Ever use of beta blockers, oral antidiabetic medications, and insulin was associated with increased mortality, HR = 1.20; 95% CI = 1.03-1.40, HR = 1.28; 95% CI = 1.05-1.55, and HR = 1.63; 95% CI = 1.20-2.20, respectively. Ever use of diuretics was inversely associated with mortality, HR = 0.71; 95% CI = 0.53-0.94.ConclusionsHistories of hypertension, diabetes, and use of diuretics, beta blockers, insulin, and oral antidiabetic medications may influence the survival of ovarian cancer patients. Understanding mechanisms for these observations could provide insight regarding treatment.

Published
2017

3. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium

Author

Minlikeeva, Albina N., Cannioto, Rikki, Jensen, Allan, Kjaer, Susanne K., Jordan, Susan J., Diergaarde, Brenda, Szender, J. Brian, Odunsi, Kunle, Almohanna, Hani, Mayor, Paul, Starbuck, Kirsten, Zsiros, Emese, Bandera, Elisa V., Cramer, Daniel W., Doherty, Jennifer A., DeFazio, Anna, Edwards, Robert, Goode, Ellen L., Goodman, Marc T., Høgdall, Estrid, Matsuo, Keitary, Mizuno, Mika, Nagle, Christina M., Ness, Roberta B., Paddock, Lisa E., Pearce, Celeste L., Risch, Harvey A., Rossing, Mary Anne, Terry, Kathryn L., Wu, Anna H., Modugno, Francesmary, Webb, Penelope M., and Moysich, Kirsten B.

Published
2019

7. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

Author

The Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, On behalf of the Ovarian Cancer Association Consortium, Faber, Mette T., Kjær, Susanne K., Dehlendorff, Christian, Chang-Claude, Jenny, Andersen, Klaus K., Høgdall, Estrid, Webb, Penelope M., Jordan, Susan J., Rossing, Mary Anne, Doherty, Jennifer A., Lurie, Galina, Thompson, Pamela J., Carney, Michael E., Goodman, Marc T., Ness, Roberta B., Modugno, Francesmary, Edwards, Robert P., Bunker, Clareann H., Goode, Ellen L., Fridley, Brooke L., Vierkant, Robert A., Larson, Melissa C., Schildkraut, Joellen, Cramer, Daniel W., Terry, Kathryn L., Vitonis, Allison F., Bandera, Elisa V., Olson, Sara H., King, Melony, Chandran, Urmila, Kiemeney, Lambertus A., Massuger, Leon F. A. G., van Altena, Anne M., Vermeulen, Sita H., Brinton, Louise, Wentzensen, Nicolas, Lissowska, Jolanta, Yang, Hannah P., Moysich, Kirsten B., Odunsi, Kunle, Kasza, Karin, Odunsi-Akanji, Oluwatosin, Song, Honglin, Pharaoh, Paul, Shah, Mitul, Whittemore, Alice S., McGuire, Valerie, Sieh, Weiva, Sutphen, Rebecca, Menon, Usha, Gayther, Simon A., Ramus, Susan J., Gentry-Maharaj, Aleksandra, Pearce, Celeste Leigh, Wu, Anna H., Pike, Malcolm C., Risch, Harvey A., and Jensen, Allan

Published
2013

12. Impact of Socioeconomic Status on Cancer Incidence and Stage at Diagnosis: Selected Findings from the Surveillance, Epidemiology, and End Results: National Longitudinal Mortality Study

Author

Clegg, Limin X., Reichman, Marsha E., Miller, Barry A., Hankey, Benjamin F., Singh, Gopal K., Lin, Yi Dan, Goodman, Marc T., Lynch, Charles F., Schwartz, Stephen M., Chen, Vivien W., Bernstein, Leslie, Gomez, Scarlett L., Graff, John J., Lin, Charles C., Johnson, Norman J., and Edwards, Brenda K.

Published
2009
Full Text
View/download PDF

22. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study

Author

Clegg, Limin X., primary, Reichman, Marsha E., additional, Miller, Barry A., additional, Hankey, Benjamin F., additional, Singh, Gopal K., additional, Lin, Yi Dan, additional, Goodman, Marc T., additional, Lynch, Charles F., additional, Schwartz, Stephen M., additional, Chen, Vivien W., additional, Bernstein, Leslie, additional, Gomez, Scarlett L., additional, Graff, John J., additional, Lin, Charles C., additional, Johnson, Norman J., additional, and Edwards, Brenda K., additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results